scholarly article | Q13442814 |
P50 | author | Serena Sanna | Q28050036 |
Albert M Kim | Q57396626 | ||
Dan Roden | Q58973971 | ||
P2093 | author name string | Calum A MacRae | |
Randall T Peterson | |||
Aravinda Chakravarti | |||
Dan E Arking | |||
John D Mably | |||
Stefan Kääb | |||
David S Rosenbaum | |||
Ian L Jones | |||
Arne Pfeufer | |||
Jeffrey R Winterfield | |||
David J Milan | |||
Adam H Amsterdam | |||
Khaled M Sabeh | |||
P2860 | cites work | Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death | Q24294267 |
Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome | Q24308735 | ||
CAPON modulates cardiac repolarization via neuronal nitric oxide synthase signaling in the heart | Q24310490 | ||
Variations in DNA elucidate molecular networks that cause disease | Q24622333 | ||
Zebrafish model for human long QT syndrome | Q30480271 | ||
The relationship between QT intervals and mortality in ambulant patients with chronic heart failure. The united kingdom heart failure evaluation and assessment of risk trial (UK-HEART) | Q78171819 | ||
Long QT syndrome in neonates: conduction disorders associated with HERG mutations and sinus bradycardia with KCNQ1 mutations | Q33151146 | ||
Drug-induced prolongation of the QT interval | Q33151147 | ||
Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. | Q33151769 | ||
Identification of 315 genes essential for early zebrafish development | Q33979931 | ||
Molecular and cellular mechanisms of cardiac arrhythmias | Q34175373 | ||
Common variants at ten loci modulate the QT interval duration in the QTSCD Study | Q34289629 | ||
The zebrafish: a new model organism for integrative physiology | Q34462661 | ||
A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization | Q34519498 | ||
Molecular physiology of cardiac repolarization | Q36267771 | ||
Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges | Q36986507 | ||
Common variants at ten loci influence QT interval duration in the QTGEN Study | Q37240241 | ||
Sea anemone toxin and scorpion toxin share a common receptor site associated with the action potential sodium ionophore | Q39213623 | ||
Infants with long-QT syndrome and 2:1 atrioventricular block | Q40373534 | ||
Ndrg4 is required for normal myocyte proliferation during early cardiac development in zebrafish | Q42945041 | ||
Drugs that induce repolarization abnormalities cause bradycardia in zebrafish | Q44365400 | ||
Zebrafish embryos express an orthologue of HERG and are sensitive toward a range of QT-prolonging drugs inducing severe arrhythmia | Q44695528 | ||
heart of glass regulates the concentric growth of the heart in zebrafish. | Q44696937 | ||
Sodium and chloride transport in soft water and hard water acclimated zebrafish (Danio rerio). | Q44732358 | ||
Deficient zebrafish ether-à-go-go-related gene channel gating causes short-QT syndrome in zebrafish reggae mutants. | Q46771674 | ||
Functional and morphological evidence for a ventricular conduction system in zebrafish and Xenopus hearts | Q46802509 | ||
santa and valentine pattern concentric growth of cardiac myocardium in the zebrafish | Q47073296 | ||
Mutations affecting the cardiovascular system and other internal organs in zebrafish | Q47073714 | ||
High-throughput assay for small molecules that modulate zebrafish embryonic heart rate. | Q50743158 | ||
Notch1b and neuregulin are required for specification of central cardiac conduction tissue. | Q52025862 | ||
Large-scale mutagenesis in the zebrafish: in search of genes controlling development in a vertebrate. | Q52218193 | ||
Clinically silent electrocardiographic abnormalities and risk of primary cardiac arrest among hypertensive patients. | Q52296424 | ||
A common polymorphism in KCNH2 (HERG) hastens cardiac repolarization | Q56982335 | ||
Common Genetic Variation in KCNH2 Is Associated With QT Interval Duration | Q57072945 | ||
Common Variants in Myocardial Ion Channel Genes Modify the QT Interval in the General Population | Q57251865 | ||
Hypothesis for the molecular physiology of the Romano-Ward long QT syndrome | Q67492586 | ||
Two:one atrioventricular block in infants with congenital long QT syndrome | Q69461350 | ||
Prolonged QT interval in hypertrophic and dilated cardiomyopathy in children | Q72688317 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Danio rerio | Q169444 |
Cell division cycle associated 8 | Q29825389 | ||
Protein kinase C, iota | Q29825993 | ||
Guided entry of tail-anchored proteins factor 1 | Q29826720 | ||
SPT6 homolog, histone chaperone and transcription elongation factor | Q29827874 | ||
UF2 component of NDC80 kinetochore complex | Q29830074 | ||
CCM2 scaffold protein | Q29830422 | ||
Replication protein A1 | Q29830826 | ||
Establishment of sister chromatid cohesion N-acetyltransferase 2 | Q29835967 | ||
Poly(A) binding protein, cytoplasmic 1a | Q86435247 | ||
P304 | page(s) | 553-559 | |
P577 | publication date | 2009-08-03 | |
P1433 | published in | Circulation | Q578091 |
P1476 | title | Drug-sensitized zebrafish screen identifies multiple genes, including GINS3, as regulators of myocardial repolarization | |
P478 | volume | 120 |
Q37873094 | A guide to analysis of cardiac phenotypes in the zebrafish embryo |
Q35577887 | Adipose tissue gene expression and metabolic health of obese adults |
Q34000857 | An enhancer polymorphism at the cardiomyocyte intercalated disc protein NOS1AP locus is a major regulator of the QT interval |
Q41783432 | An in vivo platform for rapid high-throughput antitubercular drug discovery |
Q33983329 | Annotation of loci from genome-wide association studies using tissue-specific quantitative interaction proteomics |
Q61444707 | Application of the Transcriptional Disease Signature (TDSs) to Screen Melanoma-Effective Compounds in a Small Fish Model |
Q33544983 | Blebbistatin effectively uncouples the excitation-contraction process in zebrafish embryonic heart |
Q34111355 | Cardiac arrhythmia:in vivoscreening in the zebrafish to overcome complexity in drug discovery |
Q35447163 | Cardiovascular pharmacogenomics |
Q37970334 | Clinical considerations of heritable factors in common heart failure |
Q37418554 | Common genetic variants in sudden cardiac death |
Q37976147 | Common genetic variation modulating cardiac ECG parameters and susceptibility to sudden cardiac death. |
Q30592648 | Congenital heart disease protein 5 associates with CASZ1 to maintain myocardial tissue integrity |
Q47604985 | Diminished PRRX1 Expression Is Associated With Increased Risk of Atrial Fibrillation and Shortening of the Cardiac Action Potential |
Q34358104 | Drug-Induced Long QT Syndrome |
Q35053225 | Electrocardiogram signals to assess zebrafish heart regeneration: implication of long QT intervals |
Q30359686 | Future translational applications from the contemporary genomics era: a scientific statement from the American Heart Association |
Q36851115 | Generation of a cre recombinase-conditional Nos1ap over-expression transgenic mouse |
Q34575300 | Genome-wide association studies of atrial fibrillation: past, present, and future |
Q83667474 | Heart failure: advances through genomics |
Q36068284 | Hooked! Modeling human disease in zebrafish |
Q34307746 | Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation |
Q38806486 | LITTLE FISH, BIG DATA: ZEBRAFISH AS A MODEL FOR CARDIOVASCULAR AND METABOLIC DISEASE. |
Q39639701 | Modulation of drug block of the cardiac potassium channel KCNA5 by the drug transporters OCTN1 and MDR1 |
Q36981670 | Mutation of wrb, a Component of the Guided Entry of Tail-Anchored Protein Pathway, Disrupts Photoreceptor Synapse Structure and Function |
Q24292961 | NOS1AP modulates intracellular Ca(2+) in cardiac myocytes and is up-regulated in dystrophic cardiomyopathy |
Q89726591 | NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis |
Q34462136 | Novel chemical suppressors of long QT syndrome identified by an in vivo functional screen |
Q33918840 | Novel genes for QTc interval. How much heritability is explained, and how much is left to find? |
Q37998351 | Optical mapping in the developing zebrafish heart |
Q27330065 | Optimisation of embryonic and larval ECG measurement in zebrafish for quantifying the effect of QT prolonging drugs |
Q48636968 | Overexpression of human amyloidogenic light chains causes heart failure in embryonic zebrafish: a preliminary report |
Q35068864 | Personalized medicine and the genotype-phenotype dilemma |
Q36970927 | Pharmacogenetics of Potassium Channel Blockers |
Q34976915 | Pharmacogenomics: the genetics of variable drug responses |
Q37146226 | Quantifying cardiac functions in embryonic and adult zebrafish |
Q24305127 | RING finger protein RNF207, a novel regulator of cardiac excitation |
Q38073317 | Recent advances in in vivo screening for antiarrhythmic drugs |
Q34164184 | Simultaneous mapping of membrane voltage and calcium in zebrafish heart in vivo reveals chamber-specific developmental transitions in ionic currents |
Q30433543 | Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop |
Q34111154 | Systems pharmacology of arrhythmias |
Q30540461 | The Popeye domain containing 2 (popdc2) gene in zebrafish is required for heart and skeletal muscle development |
Q34024345 | The developing zebrafish (Danio rerio): a vertebrate model for high-throughput screening of chemical libraries |
Q30502828 | The regenerative capacity of zebrafish reverses cardiac failure caused by genetic cardiomyocyte depletion. |
Q42778078 | The transcriptional response of skin to fluorescent light exposure in viviparous (Xiphophorus) and oviparous (Danio, Oryzias) fishes |
Q37659191 | The zebrafish model system in cardiovascular research: A tiny fish with mighty prospects |
Q37794882 | The zebrafish:scalable in vivo modeling for systems biology |
Q38130427 | To replicate or not to replicate: the case of pharmacogenetic studies: Establishing validity of pharmacogenomic findings: from replication to triangulation. |
Q38043058 | Uncovering the molecular and cellular mechanisms of heart development using the zebrafish. |
Q64894770 | Using Zebrafish for High-Throughput Screening of Novel Cardiovascular Drugs. |
Q37621615 | Using systems approaches to address challenges for clinical implementation of pharmacogenomics. |
Q27309211 | ZebraBeat: a flexible platform for the analysis of the cardiac rate in zebrafish embryos |
Q38019209 | Zebrafish models in cardiac development and congenital heart birth defects |
Search more.